BridgeMD
New treatment option for Spinal Cord Injury
Official title Improve Dynamic Lateral Balance of Humans With SCI
ClinicalTrials.gov ID: NCT02991248
What this study is testing
- What it's testing
- This study is to test whether pelvis perturbation training paired with transcutaneous spinal direct current stimulation (tsDCS) will be effective in improving dynamic balance and locomotor function in humans with SCI. One group will receive pelvis perturbation training paired with tsDCS, one group will receive pelvis perturbation training paired with sham, and one group will receive treadmill training only.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- age between 18 and 65 years;
- medically stable with medical clearance to participate;
- level of the SCI lesion between C4-T10;
- passive range of motion of the legs within functional limits of ambulation;
- ability to walk on a treadmill for more than 20 minutes with partial body weight support as needed and short sitting/standing breaks;
You likely can't join if
- the presence of unhealed decubiti, existing infection, severe cardiovascular and pulmonary disease, concomitant central or peripheral neurological...
- history of recurrent fractures and/or known orthopedic injury to the lower extremities;
- Botox injection within 6 months of starting the study, and current receiving physical therapy treatment;
- have metallic implantation in the spinal region underneath where electrodes may be placed.
See the full eligibility criteria
- age between 18 and 65 years;
- medically stable with medical clearance to participate;
- level of the SCI lesion between C4-T10;
- passive range of motion of the legs within functional limits of ambulation;
- ability to walk on a treadmill for more than 20 minutes with partial body weight support as needed and short sitting/standing breaks;
- ability to ambulate without orthotics or with orthotics that do not cross the knee for more than 10 meters
- the presence of unhealed decubiti, existing infection, severe cardiovascular and pulmonary disease, concomitant central or peripheral neurological injury (e.g. traumatic head injury or peripheral nerve damage in lower...
- history of recurrent fractures and/or known orthopedic injury to the lower extremities;
- Botox injection within 6 months of starting the study, and current receiving physical therapy treatment;
- have metallic implantation in the spinal region underneath where electrodes may be placed.
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.